Cargando…

2,3-Dihydroquinazolin-4(1H)-one as a privileged scaffold in drug design

2,3-Dihydroquinazolin-4-one (DHQ) belongs to the class of nitrogen-containing heterocyclic compounds representing a core structural component in various biologically active compounds. In the past decades, several methodologies have been developed for the synthesis of the DHQ framework, especially th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Badolato, Mariateresa, Aiello, Francesca, Neamati, Nouri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2018
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080947/ https://www.ncbi.nlm.nih.gov/pubmed/35542353 http://dx.doi.org/10.1039/c8ra02827c

Ejemplares similares

An Aqueous Facile Synthesis of 2,3-Dihydroquinazolin-4(1H)-One Derivatives by Reverse Zinc Oxide Micelles as Nanoreactor
por: Mou, Jie, et al.
Publicado: (2020)

Synthesis and characterization of novel hercynite@sulfuric acid and its catalytic applications in the synthesis of polyhydroquinolines and 2,3-dihydroquinazolin-4(1H)-ones
por: Mohammadi, Masoud, et al.
Publicado: (2022)

2,2,7-Trimethyl-2,3-dihydroquinazolin-4(1H)-one
por: Zhang, Ling, et al.
Publicado: (2009)

β-Cyclodextrin: a supramolecular catalyst for metal-free approach towards the synthesis of 2-amino-4,6-diphenylnicotinonitriles and 2,3-dihydroquinazolin-4(1H)-one
por: Mitra, Bijeta, et al.
Publicado: (2021)

An efficient approach for the green synthesis of biologically active 2,3-dihydroquinazolin-4(1H)-ones using a magnetic EDTA coated copper based nanocomposite
por: Kohli, Sahil, et al.
Publicado: (2023)

Unique and outstanding catalytic behavior of a novel MOF@COF composite as an emerging and powerful catalyst in the preparation of 2,3-dihydroquinazolin-4(1H)-one derivatives
por: Ghasemzadeh, Mohammad Ali, et al.
Publicado: (2023)

2-(2-Chlorophenyl)-2,3-dihydroquinazolin-4(1H)-one
por: Li, Ming-Jian, et al.
Publicado: (2009)

3-Benzyl-6-methyl-2-sulfanylidene-2,3-dihydroquinazolin-4(1H)-one
por: Al-Salahi, Rashad, et al.
Publicado: (2012)

Synthesis of benzo[4,5]imidazo[1,2-a]pyrimidines and 2,3-dihydroquinazolin-4(1H)-ones under metal-free and solvent-free conditions for minimizing waste generation
por: Tran, Phuong Hoang, et al.
Publicado: (2018)

2-(4-Bromophenyl)-2-methyl-2,3-dihydroquinazolin-4(1H)-one
por: Zhang, Mei-Mei, et al.
Publicado: (2010)

6-Chloro-3-phenethyl-2-thioxo-2,3-dihydroquinazolin-4(1H)-one
por: Hashim, Norhafizah Mohd, et al.
Publicado: (2010)

Molecular and metabolic alterations of 2,3-dihydroquinazolin-4(1H)-one derivatives in prostate cancer cell lines
por: Dahabiyeh, Lina A., et al.
Publicado: (2022)

An overview of metal-free synthetic routes to isoxazoles: the privileged scaffold
por: Das, Soumyadip, et al.
Publicado: (2021)

Co-aminobenzamid@Al-SBA-15: a favorable catalyst in synthesis of 2,3-dihydroquinazolin-4(1H)-ones
por: Safaei-Ghomi, Javad, et al.
Publicado: (2019)

Facile and diastereoselective arylation of the privileged 1,4-dihydroisoquinolin-3(2H)-one scaffold
por: Dar’in, Dmitry, et al.
Publicado: (2022)

Flavonoids and related privileged scaffolds as potential urease inhibitors: a review
por: Al-Rooqi, Munirah M., et al.
Publicado: (2023)

A Simple, Efficient, and Eco-Friendly Method for the Preparation of 3-Substituted-2,3-dihydroquinazolin-4(1H)-one Derivatives
por: Almarhoon, Zainab, et al.
Publicado: (2019)

Using hyperpolarised NMR and DFT to rationalise the unexpected hydrogenation of quinazoline to 3,4-dihydroquinazoline
por: Richards, Josh E., et al.
Publicado: (2018)

2-Methyl-2-phenyl-1,2-dihydroquinazolin-4(3H)-one
por: Zhang, Lijun, et al.
Publicado: (2008)

The Fellowship of Privileged Scaffolds—One Structure to Inhibit Them All
por: Skoreński, Marcin, et al.
Publicado: (2021)

(S)-2-(3-Nitrophenyl)-1,2-dihydroquinazolin-4(3H)-one
por: Zhang, Lijun, et al.
Publicado: (2008)

Pyrrolo[2,3‐d]pyrimidine (7‐deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides
por: Perlíková, Pavla, et al.
Publicado: (2017)

Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors
por: Melis, Claudia, et al.
Publicado: (2016)

Synthesis, Structural Studies, and α-Glucosidase Inhibitory, Antidiabetic, and Antioxidant Activities of 2,3-Dihydroquinazolin-4(1H)-ones Derived from Pyrazol-4-carbaldehyde and Anilines
por: Barmak, Alireza, et al.
Publicado: (2019)

Crystal structure of 3-benzyl-2-[(E)-2-(furan-2-yl)ethenyl]-2,3-dihydroquinazolin-4(1H)-one and 3-benzyl-2-[(E)-2-(thiophen-2-yl)ethenyl]-2,3-dihydroquinazolin-4(1H)-one from synchrotron X-ray diffraction
por: Toze, Flavien A. A., et al.
Publicado: (2018)

Sulfamic acid grafted to cross-linked chitosan by dendritic units: a bio-based, highly efficient and heterogeneous organocatalyst for green synthesis of 2,3-dihydroquinazoline derivatives
por: Valiey, Ehsan, et al.
Publicado: (2022)

2-Aryl-3-(arylideneamino)-1,2-dihydroquinazoline-4(3H)-ones as inhibitors of cholinesterases and self-induced β-amyloid (Aβ) aggregation: biological evaluations and mechanistic insights from molecular dynamics simulations
por: Sukumaran, Sri Devi, et al.
Publicado: (2018)

2-(5-Bromo-2-hydroxyphenyl)-1,2-dihydroquinazolin-4(3H)-one
por: M. Boghaei, Davar, et al.
Publicado: (2008)

(S,E)-3-[(2-Hydroxybenzylidene)amino]-2-(2-hydroxyphenyl)-2,3-dihydroquinazolin-4(1H)-one
por: Tinguiano, Daniel, et al.
Publicado: (2012)

The green chemistry of chalcones: Valuable sources of privileged core structures for drug discovery
por: Marotta, Ludovica, et al.
Publicado: (2022)

I(2)/TBHP mediated domino synthesis of 2-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)-N-aryl/alkyl benzamides and evaluation of their anticancer and docking studies
por: Soda, Anil Kumar, et al.
Publicado: (2022)

2-Methyl-4-phenyl-3,4-dihydroquinazoline
por: Valkonen, Arto, et al.
Publicado: (2011)

Redetermination at 113 K of 2,2-tetramethylene-1,2-dihydroquinazolin-4(3H)-one
por: Zhang, Lijun, et al.
Publicado: (2008)

Fluorinated triazoles as privileged potential candidates in drug development—focusing on their biological and pharmaceutical properties
por: Ullah, Ihsan, et al.
Publicado: (2022)

Sulfonyl fluorides as privileged warheads in chemical biology
por: Narayanan, Arjun, et al.
Publicado: (2015)

Larvicidal Activities of 2-Aryl-2,3-Dihydroquinazolin -4-ones against Malaria Vector Anopheles arabiensis, In Silico ADMET Prediction and Molecular Target Investigation
por: Venugopala, Katharigatta N., et al.
Publicado: (2020)

Three-component reaction between isatoic anhydride, amine and methyl-substituted furylacrylaldehydes: crystal structures of 3-benzyl-2-[(E)-2-(5-methylfuran-2-yl)vinyl]-2,3-dihydroquinazolin-4(1H)-one, 3-benzyl-2-[(E)-2-(furan-2-yl)-1-methylvinyl]-2,3-dihydroquinazolin-4(1H)-one and 3-(furan-2-ylmethyl)-2-[(E)-2-(furan-2-yl)-1-methylvinyl]-2,3-dihydroquinazolin-4(1H)-one
por: Zaytsev, Vladimir P., et al.
Publicado: (2018)

Syntheses of 3,4- and 1,4-dihydroquinazolines from 2-aminobenzylamine
por: Díaz, Jimena E, et al.
Publicado: (2017)

LmrR: A Privileged Scaffold for Artificial Metalloenzymes
por: Roelfes, Gerard
Publicado: (2019)

Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry
por: Barresi, Elisabetta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gijruonrr923avif5vifqkkgt6